Aequus Announces Canadian Filing of NDS for Preservative-Free Glaucoma Medication

Health Canada Submission of Preservative-Free Prescription ‘Zimed PF’ Accepted for Screening

VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), ) (“Aequus” or the “Company”), a specialty pharmaceutical company announced today that it has submitted a New Drug Submission (NDS) application to Health Canada for preservative-free bimatoprost 0.03% eye drops termed ‘Zimed PF’. At this stage, Health Canada has accepted the submission for Screening.

Read more at globenewswire.com